Founder, @Slingshot_Invst - Biotech focused investor - Former HF Healthcare Analyst - Tweets are my view not a rec. - William & Mary Alum
New York / LA / CO
Joined April 2013
- Tweets7.6K
- Following1.5K
- Followers3.3K
- Likes3.1K
Pinned Tweet
Great to see the momentum at Slingshot Insights to start 2026. 7 Calls today on the platform!
Our sales team just sent over this new slide I like a lot.
If you need private calls on anything please send me an email!
With all the debate about AC in the EU/UK vs. USA it would be interesting to see @Whoop data. What does a 95 degree day do to recovery & sleep in places of limited vs. bountiful AC? Excess mortality should be enough, but surely the costs don't stop there! @WHOOP @willahmed
With the SpaceX ($SPCX) IPO coming up, we've had a number of interviews on @Slingshot_Invst about the business.
Check them all out at the link below!
Just had a sales call where the client told me it was @claudeai that recommended @Slingshot_Invst specifically as the best expert network for his firm's needs.
We're launching a number of exciting new tools this month that I can't wait to share with you all.
So SGA is the best nba player? The nba says yep this is what we think is our best?
Can’t wait for the knicks to give him some of the fouls he seems to want so badly 💾
Call on $HIMX today & the thesis it can evolve from a legacy display driver supplier into a meaningful player in co-packaged optics and next-generation AI infrastructure.
Busy week of calls at Slingshot Insights we're at 18 already!
Link to all Expert Calls in reply below:
Between these hacks and how Claude Opus 4.7 reminds me of an Open AI model in early 2025...making it hard to believe the tools, agents, and even chat windows are institutional level reliable over long time periods
Having a lot of fun making things w/ @claudeai lately
I built Suite Finder last night to solve a problem that has annoyed me for years.
Finding: Premium Rooms Booking(.)com only shows basic rooms w/o clicking into hotel listing.
No more! Thoughts? suitefinder.ai
Talking to the CEO and CFO of $NSRX about NS002 data. This is an epinephrine intranasal powder candidate in development for the treatment of anaphylaxis.
Join us live or read the transcript later: slingshotinsights.com/projec…
Happening now!
On Monday at 11am ET I'll be interviewing the Management of Nasus ($NSRX) to learn more about the recent NS002 Phase 2 data for the intranasal treatment of anaphylaxis on the Slingshot Insights Platform.
What questions do you have for management?
(Link In Replies)
Interesting tension in my $PRGO call. Expert said rebuild of plant was probably too expensive to be worth it.
BUT etailers want private label formula. No options, want to deal w/ a vendor who does many OTC things.
Balance sheet makes it all tough to capitalize on though...hmm
Talking with someone who worked at $PRGO for 5+ years in the Infant Formula business. Really interested in how much of an opportunity there is in the business to turn around or divest it. I'm live with him now, so join me and add your questions. (Link below in the reply)